# Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study

> **NCT06607302** · — · RECRUITING · sponsor: **iOMEDICO AG** · enrollment: 100 (estimated)

## Conditions studied

- Cholangiocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06607302
- **Lead sponsor:** iOMEDICO AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-08
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607302, "Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06607302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*